AZZ Quarterly Cash Flow Statements Chart
Quarterly
|
Annual
AZZ Quarterly Cash Flow Statements Table
Quarterly
|
Annual
Unit: USD | 2025-05-31 | 2025-02-28 | 2024-11-30 | 2024-08-31 | 2024-05-31 | 2024-02-29 | 2023-11-30 | 2023-08-31 | 2023-05-31 | 2023-02-28 | 2022-11-30 | 2022-08-31 | 2022-05-31 | 2022-02-28 | 2021-11-30 | 2021-08-31 | 2021-05-31 | 2021-02-28 | 2020-11-30 | 2020-08-31 | 2020-05-31 | 2020-02-29 | 2019-11-30 | 2019-08-31 | 2019-05-31 | 2019-02-28 | 2018-11-30 | 2018-08-31 | 2018-05-31 | 2018-02-28 | 2017-11-30 | 2017-08-31 | 2017-05-31 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash flows from operating activities | |||||||||||||||||||||||||||||||||
net income available to common shareholders | 170,908,000 | 20,209,000 | 33,603,000 | 35,419,000 | -36,796,000 | 14,263,000 | 23,290,000 | 24,732,000 | 24,922,000 | -2,539,000 | -24,142,000 | ||||||||||||||||||||||
plus: dividends on series a preferred stock | 0 | 0 | 0 | 1,200,000 | |||||||||||||||||||||||||||||
plus: redemption premium on series a preferred stock | 0 | 0 | 0 | 75,198,000 | |||||||||||||||||||||||||||||
net income | 170,908,000 | 33,603,000 | 35,419,000 | 39,602,000 | 24,077,000 | 21,622,000 | 21,085,000 | 18,978,000 | 22,337,000 | 16,160,000 | 19,703,000 | -1,790,000 | 5,541,000 | -10,643,000 | 22,035,000 | 15,558,000 | 21,284,000 | 8,851,000 | 15,395,000 | 11,244,000 | 15,718,000 | 23,487,000 | 113,000 | 8,329,000 | 13,240,000 | ||||||||
adjustments to reconcile net income to net cash from operating activities: | |||||||||||||||||||||||||||||||||
bad debt expense | 320,000 | 5,124,000 | -67,000 | -329,000 | 330,000 | -26,000 | 61,000 | 18,000 | -20,000 | -37,000 | 116,000 | 28,000 | -303,000 | -218,000 | |||||||||||||||||||
depreciation and amortization | 21,827,000 | 20,822,000 | 20,633,000 | 20,427,000 | 20,323,000 | 20,389,000 | 20,357,000 | 20,153,000 | 18,524,000 | 18,777,000 | 21,938,000 | ||||||||||||||||||||||
deferred income taxes | -4,056,000 | 548,000 | 2,540,000 | 1,717,000 | 3,164,000 | 4,959,000 | 2,382,000 | -634,000 | -2,022,000 | 27,428,000 | 1,402,000 | -19,101,000 | -2,722,000 | 8,422,000 | -4,001,000 | -62,000 | -892,000 | 3,099,000 | 833,000 | -3,346,000 | -2,147,000 | 1,869,000 | -619,000 | -4,535,000 | 668,000 | 2,198,000 | 1,066,000 | -172,000 | 639,000 | -22,999,000 | 1,680,000 | -285,000 | 967,000 |
equity in earnings of unconsolidated entities | -173,523,000 | -3,693,000 | -7,168,000 | -1,478,000 | -3,824,000 | -4,271,000 | -8,742,000 | -974,000 | -1,420,000 | -1,591,000 | |||||||||||||||||||||||
distribution on investment in avail joint venture | 273,223,000 | 5,801,000 | 1,609,000 | 4,616,000 | 539,000 | ||||||||||||||||||||||||||||
restructuring charges | 3,744,000 | ||||||||||||||||||||||||||||||||
net gain on sale of property, plant and equipment | -2,686,000 | 29,000 | 90,000 | -471,000 | -16,000 | 117,000 | -520,000 | 212,000 | |||||||||||||||||||||||||
amortization of debt financing costs | 3,198,000 | 3,154,000 | 3,140,000 | 3,110,000 | 3,109,000 | 3,066,000 | 3,043,000 | 3,033,000 | 3,029,000 | ||||||||||||||||||||||||
share-based compensation expense | 5,086,000 | 2,017,000 | 3,796,000 | 4,913,000 | 2,535,000 | 3,303,000 | 2,188,000 | 2,115,000 | 1,904,000 | 1,244,000 | 2,368,000 | 2,772,000 | 1,998,000 | 2,907,000 | 1,860,000 | 2,871,000 | 1,811,000 | 1,557,000 | 1,690,000 | 2,317,000 | 1,766,000 | 1,386,000 | 1,818,000 | 1,736,000 | 1,350,000 | 1,324,000 | -324,000 | 2,301,000 | 1,358,000 | 1,311,000 | 1,410,000 | 2,206,000 | 1,194,000 |
changes in current assets and current liabilities | 17,768,000 | 14,201,000 | 11,402,000 | -16,103,000 | 7,610,000 | 15,183,000 | 17,435,000 | ||||||||||||||||||||||||||
changes in other long-term assets and long-term liabilities | -1,027,000 | -3,900,000 | -3,411,000 | -4,335,000 | -1,428,000 | -45,000 | -913,000 | ||||||||||||||||||||||||||
net cash from operating activities | 314,782,000 | 66,167,000 | 47,486,000 | 71,944,000 | 23,314,000 | 11,910,000 | 26,698,000 | 11,060,000 | 27,228,000 | 43,350,000 | -11,184,000 | 33,819,000 | 56,822,000 | -18,587,000 | 42,928,000 | 29,833,000 | -12,366,000 | 35,925,000 | 18,589,000 | -15,804,000 | |||||||||||||
capex | -20,896,000 | -26,441,000 | -32,105,000 | -27,396,000 | -7,809,000 | -6,032,000 | -5,610,000 | -7,489,000 | -8,616,000 | -8,422,000 | -10,847,000 | -6,047,000 | -11,810,000 | -4,686,000 | -6,512,000 | -4,332,000 | -2,847,000 | -4,897,000 | -6,495,000 | -10,141,000 | |||||||||||||
free cash flows | 293,886,000 | 39,726,000 | 15,381,000 | 44,548,000 | 15,505,000 | 5,878,000 | 21,088,000 | 3,571,000 | 18,612,000 | 34,928,000 | -22,031,000 | 27,772,000 | 45,012,000 | -23,273,000 | 36,416,000 | 25,501,000 | -15,213,000 | 31,028,000 | 12,094,000 | -25,945,000 | |||||||||||||
cash flows from investing activities | |||||||||||||||||||||||||||||||||
purchase of property, plant and equipment | -20,896,000 | -29,941,000 | -26,441,000 | -32,105,000 | -27,396,000 | -28,219,000 | -24,174,000 | -25,690,000 | -17,036,000 | -22,035,000 | -16,389,000 | -10,887,000 | -7,809,000 | -6,032,000 | -5,610,000 | -7,489,000 | -8,616,000 | -8,422,000 | -10,847,000 | -6,047,000 | -11,810,000 | -4,686,000 | -6,512,000 | -4,332,000 | -2,847,000 | -4,897,000 | -6,495,000 | -10,141,000 | |||||
proceeds from sale of property, plant and equipment | 3,774,000 | 81,000 | 33,000 | 169,000 | 2,514,000 | 23,000 | 57,000 | 5,000 | 122,000 | 210,000 | 23,000 | ||||||||||||||||||||||
net cash from investing activities | -17,122,000 | -26,360,000 | -31,361,000 | -27,379,000 | -1,306,289,000 | -5,863,000 | -3,096,000 | -7,466,000 | -4,456,000 | 316,000 | -10,847,000 | -26,746,000 | -12,619,000 | -43,469,000 | -6,489,000 | -3,993,000 | -10,847,000 | -27,465,000 | -16,739,000 | -9,970,000 | |||||||||||||
cash flows from financing activities | |||||||||||||||||||||||||||||||||
proceeds from issuance of common stock | 1,226,000 | 0 | 899,000 | 1,000 | 605,000 | 0 | 1,244,000 | 0 | 1,138,000 | 0 | 1,332,000 | 0 | |||||||||||||||||||||
redemption of series a preferred stock | 0 | -308,920,000 | |||||||||||||||||||||||||||||||
tax payments related to common stock issued under stock-based plans | -4,598,000 | ||||||||||||||||||||||||||||||||
proceeds from revolving credit facility | 210,000,000 | 55,000,000 | 78,000,000 | ||||||||||||||||||||||||||||||
payments on revolving credit facility | -160,000,000 | -65,000,000 | -113,000,000 | ||||||||||||||||||||||||||||||
payments of debt financing costs | -20,000 | -362,000 | -826,000 | 0 | -715,000 | -400,000 | -96,000 | 7,000 | -4,858,000 | 4,858,000 | -87,555,000 | ||||||||||||||||||||||
payments on long term debt and finance leases | -335,809,000 | -106,000 | |||||||||||||||||||||||||||||||
payments of dividends | -5,085,000 | -5,086,000 | -5,079,000 | -5,076,000 | -7,867,000 | -7,867,000 | -7,864,000 | -7,852,000 | -7,835,000 | -10,075,000 | -4,246,000 | -4,226,000 | -4,192,000 | -4,163,000 | -4,265,000 | -4,245,000 | -4,432,000 | -4,467,000 | -4,425,000 | -4,461,000 | -4,454,000 | -4,440,000 | -4,435,000 | -4,426,000 | -4,418,000 | -4,421,000 | -4,422,000 | -4,423,000 | |||||
net cash from financing activities | -295,512,000 | -41,162,000 | -24,208,000 | -38,542,000 | 1,368,940,000 | -2,819,000 | -20,738,000 | -5,610,000 | -19,098,000 | -56,167,000 | 11,036,000 | -5,987,000 | -44,364,000 | 51,560,000 | -27,435,000 | -30,926,000 | 16,796,000 | -1,755,000 | -4,924,000 | 20,890,000 | |||||||||||||
effect of exchange rate changes on cash | -593,000 | 372,000 | 687,000 | -311,000 | 174,000 | -45,000 | 25,000 | -704,000 | 737,000 | 2,704,000 | -4,700,000 | 2,550,000 | -49,000 | 1,639,000 | 221,000 | -418,000 | 1,493,000 | 115,000 | 722,000 | -380,000 | 158,000 | 77,000 | -795,000 | 352,000 | -498,000 | 397,000 | 286,000 | -81,000 | |||||
net increase in cash and cash equivalents | 1,555,000 | 4,000 | 6,197,000 | -3,160,000 | 1,058,000 | -470,000 | -11,050,000 | -86,658,000 | 85,916,000 | 4,867,000 | |||||||||||||||||||||||
cash and cash equivalents at beginning of period | 1,488,000 | 0 | 0 | 0 | 4,349,000 | 0 | 0 | 0 | 2,820,000 | 0 | 0 | 15,082,000 | 0 | 0 | 14,837,000 | 0 | 0 | 36,687,000 | 0 | 0 | 24,005,000 | 0 | 0 | 20,853,000 | |||||||||
cash and cash equivalents at end of period | 3,043,000 | -668,000 | -8,394,000 | 10,546,000 | -1,770,000 | 3,878,000 | -11,050,000 | -86,658,000 | 100,998,000 | 4,867,000 | 3,085,000 | 12,403,000 | 5,167,000 | -12,386,000 | 26,414,000 | 706,000 | -3,000 | 13,586,000 | 8,209,000 | -4,734,000 | 13,938,000 | ||||||||||||
common stock | |||||||||||||||||||||||||||||||||
shares | |||||||||||||||||||||||||||||||||
balance at march 31, 2025 | |||||||||||||||||||||||||||||||||
share-based compensation | |||||||||||||||||||||||||||||||||
common stock issued under stock-based plans and related tax expense | 22,000 | 112,000 | -92,000 | 112,000 | |||||||||||||||||||||||||||||
cash dividends paid on common stock | |||||||||||||||||||||||||||||||||
other comprehensive income | |||||||||||||||||||||||||||||||||
balance at may 31, 2025 | |||||||||||||||||||||||||||||||||
less: net income from discontinued operations | -6,366,000 | -38,969,000 | |||||||||||||||||||||||||||||||
net income from continuing operations | 17,863,000 | 26,890,000 | 28,332,000 | 28,522,000 | 7,427,000 | 18,427,000 | |||||||||||||||||||||||||||
adjustments to reconcile net income from continuing operations to net cash from operating activities: | |||||||||||||||||||||||||||||||||
loss on abandonment of long-lived assets | |||||||||||||||||||||||||||||||||
net cash from operating activities of continuing operations | 63,540,000 | 62,588,000 | 71,447,000 | 46,893,000 | 22,808,000 | 26,611,000 | |||||||||||||||||||||||||||
proceeds from sale of subsidiaries | |||||||||||||||||||||||||||||||||
acquisition of subsidiaries, net of cash acquired | 718,000 | 15,065,000 | 0 | -1,298,513,000 | 0 | -20,704,000 | -931,000 | -38,993,000 | 0 | 0 | 0 | -8,000,000 | -11,944,000 | -22,591,000 | |||||||||||||||||||
proceeds from sale or insurance settlements of property, plant and equipment | 7,000 | 25,000 | |||||||||||||||||||||||||||||||
net cash from investing activities of continuing operations | -28,211,000 | -24,147,000 | -25,679,000 | -17,027,000 | -21,268,000 | 105,467,000 | |||||||||||||||||||||||||||
payments for taxes related to net share settlement of equity awards | -4,567,000 | -920,000 | 0 | 919,000 | -1,710,000 | -408,000 | -286,000 | 7,000 | -2,313,000 | -18,000 | -20,000 | -48,000 | -2,101,000 | -66,000 | -92,000 | -15,000 | -539,000 | -14,000 | -526,000 | ||||||||||||||
proceeds from long term debt | 0 | 0 | 0 | 1,540,000,000 | |||||||||||||||||||||||||||||
payments on long term debt and finance lease liabilities | -20,299,000 | -257,000 | -60,236,000 | -30,196,000 | |||||||||||||||||||||||||||||
net cash from financing activities of continuing operations | -38,444,000 | -33,065,000 | -46,834,000 | -29,545,000 | 21,879,000 | -239,640,000 | |||||||||||||||||||||||||||
net cash from operating activities from discontinued operations | -29,248,000 | -17,125,000 | |||||||||||||||||||||||||||||||
net cash from investing activities from discontinued operations | 2,655,000 | -1,663,000 | |||||||||||||||||||||||||||||||
net cash from financing activities from discontinued operations | 0 | ||||||||||||||||||||||||||||||||
net cash from discontinued operations | |||||||||||||||||||||||||||||||||
cash and cash equivalents from continuing operations at end of period | -3,160,000 | 5,401,000 | -1,770,000 | 3,878,000 | -8,050,000 | ||||||||||||||||||||||||||||
balance at february 28, 2022 | |||||||||||||||||||||||||||||||||
common stock issued under employee stock purchase plan | 27,000 | 0 | |||||||||||||||||||||||||||||||
dividends on series a preferred stock | |||||||||||||||||||||||||||||||||
cash dividends paid on common shares | |||||||||||||||||||||||||||||||||
balance at february 28, 2023 | 24,672,000 | 0 | |||||||||||||||||||||||||||||||
balance at february 29, 2024 | 0 | 0 | 0 | 25,102,000 | |||||||||||||||||||||||||||||
common stock issued | |||||||||||||||||||||||||||||||||
redemption premium on series a preferred stock | |||||||||||||||||||||||||||||||||
other comprehensive loss | |||||||||||||||||||||||||||||||||
balance at february 28, 2025 | |||||||||||||||||||||||||||||||||
redemption of preferred stock | |||||||||||||||||||||||||||||||||
tax payments related to net share settlement of equity awards | 0 | ||||||||||||||||||||||||||||||||
balance at august 31, 2024 | 0 | ||||||||||||||||||||||||||||||||
balance at november 30, 2024 | |||||||||||||||||||||||||||||||||
secondary public offering and issuance of additional common stock | 4,600,000 | ||||||||||||||||||||||||||||||||
net decrease in cash and cash equivalents | -2,434,000 | 5,167,000 | -12,386,000 | -10,273,000 | 706,000 | -3,000 | -10,419,000 | 8,209,000 | -4,734,000 | -6,915,000 | |||||||||||||||||||||||
balance at may 31, 2024 | 0 | 29,814,000 | |||||||||||||||||||||||||||||||
other investing activities | 17,000 | 8,000 | 27,000 | 11,000 | 9,000 | ||||||||||||||||||||||||||||
proceeds from secondary public offering and issuance of additional common stock | 308,723,000 | ||||||||||||||||||||||||||||||||
proceeds from revolving loan | 75,000,000 | 60,000,000 | 47,000,000 | 50,000,000 | 92,000,000 | 125,000,000 | 80,000,000 | 136,000,000 | 39,000,000 | 80,000,000 | 34,000,000 | 147,000,000 | 35,000,000 | 67,000,000 | 65,000,000 | 20,000,000 | 76,000,000 | 108,000,000 | 101,000,000 | 32,500,000 | 187,000,000 | 52,000,000 | 34,000,000 | 75,500,000 | 102,500,000 | 76,000,000 | 64,000,000 | 81,000,000 | 128,000,000 | ||||
payments on revolving loan | -70,000,000 | -40,000,000 | -72,000,000 | -90,000,000 | -112,000,000 | -40,000,000 | -97,000,000 | -109,000,000 | -116,000,000 | -45,000,000 | -25,000,000 | -150,000,000 | -28,000,000 | -95,000,000 | -55,000,000 | -67,000,000 | -60,000,000 | -160,000,000 | -102,000,000 | -73,500,000 | -131,000,000 | -84,000,000 | -57,000,000 | -102,000,000 | -67,000,000 | -82,000,000 | -59,000,000 | -79,000,000 | -36,500,000 | ||||
net (income) income from discontinued operations | |||||||||||||||||||||||||||||||||
plus: dividends on preferred stock | 3,600,000 | 3,600,000 | |||||||||||||||||||||||||||||||
other non-cash items | |||||||||||||||||||||||||||||||||
proceeds from divestiture | |||||||||||||||||||||||||||||||||
repurchase and retirement of treasury stock | -7,636,000 | -14,969,000 | -6,264,000 | ||||||||||||||||||||||||||||||
less: cash and cash equivalents from discontinued operations at end of period | |||||||||||||||||||||||||||||||||
balance at february 28, 2021 | |||||||||||||||||||||||||||||||||
repurchase and retirement of common stock | |||||||||||||||||||||||||||||||||
dividends on preferred stock | |||||||||||||||||||||||||||||||||
impairment of long-lived assets | 100,000 | ||||||||||||||||||||||||||||||||
net (gain) on sale of property, plant and equipment | -26,000 | -11,000 | -2,000 | ||||||||||||||||||||||||||||||
balance at august 31, 2023 | 0 | ||||||||||||||||||||||||||||||||
dividends paid on common shares | |||||||||||||||||||||||||||||||||
balance at november 30, 2023 | |||||||||||||||||||||||||||||||||
common stock issued under stock-based plans and related income tax expense | |||||||||||||||||||||||||||||||||
balance at may 31, 2023 | |||||||||||||||||||||||||||||||||
foreign currency translation | |||||||||||||||||||||||||||||||||
interest rate swap | |||||||||||||||||||||||||||||||||
plus: accrued dividends on preferred stock | 3,600,000 | 3,600,000 | |||||||||||||||||||||||||||||||
effects of changes in assets and liabilities, net of acquisitions and dispositions: | |||||||||||||||||||||||||||||||||
accounts receivable | 12,936,000 | -10,115,000 | 19,383,000 | -25,188,000 | -10,625,000 | -15,765,000 | -10,934,000 | 56,000 | -7,966,000 | -1,789,000 | -9,971,000 | 10,965,000 | 8,721,000 | 27,082,000 | -18,909,000 | 5,049,000 | -14,228,000 | 5,824,000 | -776,000 | 16,398,000 | -29,577,000 | 19,246,000 | -16,693,000 | 15,053,000 | -14,114,000 | ||||||||
inventories | -1,198,000 | -2,552,000 | 1,435,000 | 2,973,000 | -19,054,000 | -11,168,000 | -3,519,000 | -4,930,000 | -8,254,000 | 3,908,000 | -1,283,000 | 3,969,000 | -4,449,000 | 19,630,000 | -9,305,000 | 7,869,000 | 7,681,000 | -2,159,000 | 3,735,000 | -809,000 | -1,362,000 | 1,817,000 | 7,914,000 | -11,722,000 | -7,936,000 | ||||||||
prepaid expenses and other | -2,494,000 | 2,005,000 | 3,043,000 | 3,214,000 | -12,452,000 | 3,403,000 | 2,696,000 | -5,419,000 | 955,000 | 2,313,000 | -941,000 | 3,546,000 | -815,000 | -1,240,000 | 1,437,000 | 3,537,000 | -5,927,000 | 1,503,000 | 1,598,000 | -5,619,000 | |||||||||||||
other assets | 43,000 | 273,000 | 304,000 | -4,554,000 | 300,000 | 46,000 | -1,827,000 | -778,000 | 24,000 | 79,000 | 123,000 | -82,000 | 183,000 | 185,000 | 11,000 | 131,000 | -1,148,000 | 1,049,000 | -87,000 | -1,019,000 | |||||||||||||
net change in contract assets and liabilities | -1,949,000 | -6,814,000 | 10,161,000 | 4,938,000 | -12,689,000 | 22,937,000 | -5,648,000 | 4,768,000 | -9,839,000 | 20,434,000 | -14,845,000 | -3,620,000 | 3,168,000 | 7,109,000 | -4,197,000 | 5,136,000 | -55,088,000 | 12,587,000 | 9,782,000 | 1,160,000 | -20,438,000 | ||||||||||||
accounts payable | -2,665,000 | 1,087,000 | -47,962,000 | -8,739,000 | 41,579,000 | 813,000 | -2,190,000 | -3,660,000 | 6,321,000 | -13,739,000 | 8,149,000 | -603,000 | -15,328,000 | -7,792,000 | 5,377,000 | 5,941,000 | 7,068,000 | 7,866,000 | 1,988,000 | -15,601,000 | 5,576,000 | 7,407,000 | 903,000 | -4,365,000 | -2,405,000 | ||||||||
other accrued liabilities and income taxes payable | -6,333,000 | -19,945,000 | -5,561,000 | 26,412,000 | -3,464,000 | -6,134,000 | 115,000 | -3,579,000 | 2,749,000 | -11,425,000 | 8,946,000 | 2,884,000 | -19,610,000 | -5,429,000 | 21,256,000 | 8,854,000 | -1,145,000 | 8,081,000 | -1,925,000 | -1,714,000 | 7,559,000 | -1,993,000 | -7,540,000 | 276,000 | -1,927,000 | ||||||||
cash from discontinued operations | -26,593,000 | 101,212,000 | |||||||||||||||||||||||||||||||
other operating cash payments | |||||||||||||||||||||||||||||||||
cash paid for interest | 25,866,000 | 4,161,000 | 2,407,000 | 351,000 | 2,910,000 | 394,000 | 3,758,000 | 435,000 | 3,937,000 | 869,000 | 4,597,000 | 1,607,000 | 5,219,000 | 1,600,000 | 4,923,000 | 2,119,000 | 5,373,000 | 2,465,000 | 4,645,000 | 1,928,000 | 4,734,000 | 2,286,000 | |||||||||||
cash paid for income taxes | 895,000 | 4,034,000 | 8,401,000 | 8,899,000 | 13,038,000 | 1,322,000 | 910,000 | 5,850,000 | 9,347,000 | 11,000 | 10,817,000 | 4,215,000 | 3,203,000 | 567,000 | 893,000 | 884,000 | 844,000 | 670,000 | 285,000 | 811,000 | 508,000 | 7,097,000 | |||||||||||
supplemental disclosures of non-cash investing and financing activities | |||||||||||||||||||||||||||||||||
accrued dividends on preferred stock | 2,400,000 | ||||||||||||||||||||||||||||||||
accruals for capital expenditures | 2,409,000 | ||||||||||||||||||||||||||||||||
loss on disposal of business | 0 | 30,000 | 1,852,000 | ||||||||||||||||||||||||||||||
net (gain) loss on sale of property, plant and equipment | 349,000 | 1,361,000 | -2,713,000 | -29,000 | -247,000 | 500,000 | -15,000 | 40,000 | -106,000 | -200,000 | |||||||||||||||||||||||
payments on long term debt | -53,250,000 | -213,250,000 | 0 | 0 | -14,286,000 | -1,000 | 0 | -63,504,000 | |||||||||||||||||||||||||
cash and cash equivalents at beginning of year | |||||||||||||||||||||||||||||||||
cash and cash equivalents at end of year | |||||||||||||||||||||||||||||||||
less: cash and cash equivalents from discontinued operations at end of year | |||||||||||||||||||||||||||||||||
cash and cash equivalents from continuing operations at end of year | |||||||||||||||||||||||||||||||||
amortization of deferred borrowing costs | 1,255,000 | 3,120,000 | 1,541,000 | 221,000 | 191,000 | 139,000 | 234,000 | 134,000 | 135,000 | 135,000 | 133,000 | 136,000 | 64,000 | 205,000 | 138,000 | 147,000 | 149,000 | 154,000 | |||||||||||||||
bad debt recoveries | -265,000 | ||||||||||||||||||||||||||||||||
amortization and depreciation | 15,119,000 | 11,139,000 | 10,999,000 | 11,084,000 | 11,027,000 | 11,481,000 | 11,668,000 | 12,624,000 | 12,258,000 | 12,326,000 | 12,370,000 | 12,627,000 | 13,071,000 | 12,856,000 | 12,561,000 | 12,423,000 | |||||||||||||||||
supplemental disclosures | |||||||||||||||||||||||||||||||||
cash flows from operating activities: | |||||||||||||||||||||||||||||||||
gain on disposal group held for sale | |||||||||||||||||||||||||||||||||
inventory write-downs | |||||||||||||||||||||||||||||||||
impairment loss on long lived assets | |||||||||||||||||||||||||||||||||
gain on sale of property, plant & equipment | |||||||||||||||||||||||||||||||||
amortization of deferred debt issuance costs | |||||||||||||||||||||||||||||||||
effects of changes in operating assets and liabilities, net of acquisitions: | |||||||||||||||||||||||||||||||||
prepaid expenses and other assets | |||||||||||||||||||||||||||||||||
net cash from operating activities: | |||||||||||||||||||||||||||||||||
cash flows from investing activities: | |||||||||||||||||||||||||||||||||
proceeds from the sale or insurance settlement of property, plant, and equipment | |||||||||||||||||||||||||||||||||
proceeds from sale of subsidiary | |||||||||||||||||||||||||||||||||
purchases of property, plant and equipment | |||||||||||||||||||||||||||||||||
net cash from investing activities: | |||||||||||||||||||||||||||||||||
cash flows from financing activities: | |||||||||||||||||||||||||||||||||
proceeds from long-term debt | |||||||||||||||||||||||||||||||||
payments on long-term debt | |||||||||||||||||||||||||||||||||
debt issuance costs paid | |||||||||||||||||||||||||||||||||
payment of dividends | |||||||||||||||||||||||||||||||||
net cash from financing activities: | |||||||||||||||||||||||||||||||||
effect of exchange rate changes on cash and cash equivalents | |||||||||||||||||||||||||||||||||
net change in cash and cash equivalents | |||||||||||||||||||||||||||||||||
cash and cash equivalents, beginning of year | |||||||||||||||||||||||||||||||||
cash and cash equivalents, end of year | |||||||||||||||||||||||||||||||||
supplemental disclosures of cash flow information: | |||||||||||||||||||||||||||||||||
loss on disposal group held for sale | |||||||||||||||||||||||||||||||||
non-cash restructuring and impairment charges | -206,000 | ||||||||||||||||||||||||||||||||
loss on sale of property, plant & equipment | |||||||||||||||||||||||||||||||||
benefit from doubtful accounts | 7,000 | 97,000 | 129,000 | 418,000 | 139,000 | -439,000 | 2,616,000 | 114,000 | -11,000 | 235,000 | 1,815,000 | 67,000 | 2,893,000 | ||||||||||||||||||||
purchases of treasury shares | -24,574,000 | 0 | -2,333,000 | -2,502,000 | -2,683,000 | ||||||||||||||||||||||||||||
effects of changes in assets and liabilities, net of acquisitions: | |||||||||||||||||||||||||||||||||
net income on property, plant and equipment due to impairment | -1,000 | ||||||||||||||||||||||||||||||||
net income on disposition of property, plant & equipment due to impairment | |||||||||||||||||||||||||||||||||
net income on sale of property, plant & equipment and insurance proceeds | |||||||||||||||||||||||||||||||||
effects of changes in assets and liabilities: | |||||||||||||||||||||||||||||||||
net (gain) loss on sale of property, plant & equipment and insurance proceeds | |||||||||||||||||||||||||||||||||
net change in billings related to costs and estimated earnings on uncompleted contracts | -3,912,000 | 21,383,000 | -5,762,000 | -10,725,000 | |||||||||||||||||||||||||||||
excess tax benefits from share-based compensation | |||||||||||||||||||||||||||||||||
net income on disposition of property, plant and equipment due to impairment | |||||||||||||||||||||||||||||||||
net income on sale of property, plant and equipment and insurance proceeds | |||||||||||||||||||||||||||||||||
proceeds from sale or insurance settlement of property, plant and equipment | |||||||||||||||||||||||||||||||||
net income on disposition of property, plant & equipment due to realignment | |||||||||||||||||||||||||||||||||
effects of changes in assets & liabilities: | |||||||||||||||||||||||||||||||||
proceeds from sale or insurance settlement of property, plant, and equipment | 6,000 | 171,000 | |||||||||||||||||||||||||||||||
net decrease in cash & cash equivalents | -2,788,000 | -4,965,000 | |||||||||||||||||||||||||||||||
cash & cash equivalents at beginning of period | 0 | 11,302,000 | |||||||||||||||||||||||||||||||
cash & cash equivalents at end of period | -2,788,000 | 6,337,000 | |||||||||||||||||||||||||||||||
provision (recovery) for doubtful accounts | 63,000 | ||||||||||||||||||||||||||||||||
net gain on sale of property, plant & equipment and insurance proceeds | -100,000 | ||||||||||||||||||||||||||||||||
debt acquisition costs | |||||||||||||||||||||||||||||||||
proceeds from exercise of stock options and stock appreciation rights | |||||||||||||||||||||||||||||||||
excess tax benefits from stock options and stock appreciation rights | |||||||||||||||||||||||||||||||||
depreciation | |||||||||||||||||||||||||||||||||
amortization | |||||||||||||||||||||||||||||||||
non-cash compensation expense | |||||||||||||||||||||||||||||||||
non-cash interest expense | |||||||||||||||||||||||||||||||||
deferred income tax expense | |||||||||||||||||||||||||||||||||
net (gain) loss on insurance settlement or sale of property, plant and equipment | |||||||||||||||||||||||||||||||||
effects of changes in operating assets and liabilities, net of business acquisitions: | |||||||||||||||||||||||||||||||||
other accrued liabilities and income taxes | |||||||||||||||||||||||||||||||||
proceeds from the sale or insurance settlement of property, plant and equipment | |||||||||||||||||||||||||||||||||
debt origination costs | |||||||||||||||||||||||||||||||||
tax benefits from stock options exercised | |||||||||||||||||||||||||||||||||
cash dividends paid | |||||||||||||||||||||||||||||||||
cash paid during the year for: | |||||||||||||||||||||||||||||||||
interest | |||||||||||||||||||||||||||||||||
income taxes | |||||||||||||||||||||||||||||||||
proceeds on revolving loan | |||||||||||||||||||||||||||||||||
proceeds from settlement of derivative | |||||||||||||||||||||||||||||||||
net gain on insurance settlement or sale of property, plant and equipment | |||||||||||||||||||||||||||||||||
share based compensation expense | |||||||||||||||||||||||||||||||||
cumulative effect of change in accounting principle | |||||||||||||||||||||||||||||||||
proceeds from exercise of stock options | |||||||||||||||||||||||||||||||||
effects of changes in operating assets and liabilities: | |||||||||||||||||||||||||||||||||
proceeds from the sale of property, plant and equipment | |||||||||||||||||||||||||||||||||
effects of changes in operating assets and liabilities, net of acquisition of subsidiaries: | |||||||||||||||||||||||||||||||||
proceeds from the sale of long-term investments | |||||||||||||||||||||||||||||||||
purchase of treasury stock |
We provide you with 20 years of cash flow statements for AZZ stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of AZZ stock. Explore the full financial landscape of AZZ stock with our expertly curated income statements.
The information provided in this report about AZZ stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.